Maiwald
Sponsored
Sponsored
-
Sponsored by MaiwaldKerstin Wolff of Maiwald reports on a proposal that supports the use of some plants generated by new genomic techniques but opposes patents for all plants obtained by such means
-
Sponsored by MaiwaldEva Ehlich and Anja Fux of Maiwald summarise an EPO board ruling relating to substances and compositions in the context of medical use claims and how it could affect applicants’ portfolio strategies
-
Sponsored by MaiwaldWhile some observers are of the view that an Enlarged Board of Appeal ruling failed to provide sufficient clarity, Eva Ehlich and Anja Fux of Maiwald say the picture concerning post-published evidence is becoming clearer
-
Sponsored by MaiwaldSusanna Heurung of Maiwald welcomes a decision by the Board of Appeal regarding the extension of a grace period for use where the applicant’s bad faith was obvious
-
Sponsored by MaiwaldIn concluding a two-part series on springboard injunctions, Marco Stief of Maiwald takes a deeper dive to explain their requirements, review case law, and examine their relevance in the pharmaceutical and life sciences sectors
-
Sponsored by MaiwaldIn the first of two articles on the springboard doctrine, Marco Stief of Maiwald explains how the protective effect of a patent can continue to have an impact after the term of protection has ended
-
Sponsored by MaiwaldGisela Grabow of Maiwald considers the potential changes to the EU’s general pharmaceutical legislation under a recent proposal, and the main questions raised for stakeholders
-
Sponsored by MaiwaldChristian Meyer of Maiwald explains several clarifications under a ruling by the German Federal Court of Justice concerning the cessation of the danger of a repeated infringement
-
Sponsored by MaiwaldBo-Hyun Lee of Maiwald considers how the Unified Patent Court will affect the successful German model of having patent attorneys and attorneys-at-law work together to handle the technical aspects of infringement proceedings
-
Sponsored by MaiwaldMarco Stief of Maiwald reports on a ruling by the CJEU that significantly extends the liability of online platforms for third-party trademark infringement and explains what it means for online marketplaces and trademark owners
-
Sponsored by MaiwaldA shift is required in the finance and banking sectors’ approach to the use of intangible capital assets as collateral, says Marco Stief of Maiwald
-
Sponsored by MaiwaldMarco Stief of Maiwald explains a ruling by the Düsseldorf Regional Court in the matter NuCana v Gilead that establishes the subsidiarity of the objection of disproportionality with regard to a compulsory licensing action
-
Sponsored by MaiwaldSusanna Heurung of Maiwald examines a decision by the European Court of Justice concerning the ending of a period of ‘acquiescence’ in a trademark case and what it means for potential plaintiffs
-
Sponsored by MaiwaldOwners of German trademarks who rely on their use in Switzerland to protect their mark must change their strategy immediately, as Susanna Heurung of Maiwald explains
-
Sponsored by MaiwaldHeike Röder-Hitschke of Maiwald discusses a significant European Court of Justice (CJEU) ruling, and how it will affect future practice in preliminary injunction proceedings
-
Sponsored by MaiwaldSimon Lud of Maiwald explains how a German court judgment is advantageous for patent applications in the fields of artificial intelligence and quantum computing
-
Sponsored by MaiwaldMatthias Hoffmann of Maiwald discusses the uncertainty over the transfer of priority rights and the joint applicants approach at the EPO
-
Sponsored by MaiwaldChristian Meyer of Maiwald discusses a case concerning the domain muenchen.de, in which a reference to a USB stick was found to be admissible in an application for an injunction